Your uterine lining is called the endometrium. When you have an ultrasound or MRI, your endometrium will show up as a dark line on the screen. This line is sometimes referred to as the “endometrial ...

Although it is known that obesity increases the risk of endometrial cancer and is linked to higher mortality rates in the general population, the association between obesity and mortality among ...

An international team including the National Cancer Center Japan analyzed trends in early-onset cancers diagnosed in 44 ...

Recent studies highlight the effectiveness of lenvatinib and pembrolizumab in improving overall survival for patients with ...

What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...

What Is an Endometrial Biopsy? An endometrial biopsy is a quick and safe procedure that usually happens in your doctor’s office. During the biopsy, your doctor removes a small piece of tissue from the ...

Endometrial hyperplasia (EH) is a condition in which the inner lining of the uterus becomes thicker and sometimes abnormal. There are different types of EH as viewed under a microscope, but the main ...

Becoming pregnant after an endometrial ablation is usually unlikely, but it can happen. Pregnancy after ablation can have a higher risk of complications. Endometrial ablation is a procedure to remove ...

Adult stem cells have captured researchers’ interest since their discovery in the 1960s. Due to their unique capacity to self-renew and differentiate into multiple cell types, scientists find them ...

Ramez N. Eskander, MD, discusses the optimal use of lenvatinib/pembrolizumab in clinical practice for patients with endometrial cancer. He provides advice for integrating this regimen into the ...

Cancer has evolved to protect itself from our inherent immune responses, and some types of cancer cells have developed their own strategies to evade or withstand treatment. These pro-cancer shields ...